Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470125) titled 'Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers' on March 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Yuhan Corporation

Condition: Healthy Subjects

Intervention: Drug: YHP2511

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: June 23, 2026

Target Sample Size: 60

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07470125

Disclaimer: Curated by HT Syndication....